Patents by Inventor Robert C. Bast

Robert C. Bast has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
    Patent number: 10533227
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with breast or ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast or ovarian cancers are provided.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: January 14, 2020
    Assignees: Millennium Pharmaceuticals, Inc., Board of Regents, University of Texas System
    Inventors: Ole Petter Veiby, Robert C. Bast, Gordon B. Mills, Gabriel N. Hortobagyi
  • COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF BREAST AND OVARIAN CANCER
    Publication number: 20160326591
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with breast or ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast or ovarian cancers are provided.
    Type: Application
    Filed: November 3, 2015
    Publication date: November 10, 2016
    Inventors: Ole Petter Veiby, Robert C. Bast, Gordon B. Mills, Gabriel N. Hortobagyi
  • Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
    Publication number: 20030124128
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.
    Type: Application
    Filed: June 21, 2002
    Publication date: July 3, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: James Lillie, Manjula Gannavarapu, Karen Glatt, Sebastian Hoersch, Shubhangi Kamatkar, Maureen Mertens, John E. Monahan, Vickesh Myer, Youzhen Wang, Yongyao Xu, Xumei Zhao, Rachel E. Meyers, Robert C. Bast, Gabriel N. Hortobagyi, Lajos Pusztai, Funda Meric, Aysegul Sahin, Gordon B. Mills
  • Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
    Publication number: 20030087250
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with ovarian cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human ovarian cancers are provided.
    Type: Application
    Filed: March 14, 2002
    Publication date: May 8, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: John E. Monahan, Manjula Gannavarapu, Sebastian Hoersch, Shubhangi Kamatkar, Steven G. Kovats, Rachel E. Meyers, Michael P. Morrisey, Peter J. Olandt, Ami Sen, Petter Ole Veiby, Gordon B. Mills, Robert C. Bast, Karen Lu, Rosemarie E. Schmandt, Xumei Zhao, Karen Glatt